NO983472L - Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene - Google Patents

Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene

Info

Publication number
NO983472L
NO983472L NO983472A NO983472A NO983472L NO 983472 L NO983472 L NO 983472L NO 983472 A NO983472 A NO 983472A NO 983472 A NO983472 A NO 983472A NO 983472 L NO983472 L NO 983472L
Authority
NO
Norway
Prior art keywords
taxoids
res
compounds
preparation
pharmaceutical preparations
Prior art date
Application number
NO983472A
Other languages
English (en)
Other versions
NO983472D0 (no
Inventor
Hervu Bouchard
Jean-Dominique Bourzat
On Alain Commer
Original Assignee
Rh Ne Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rh Ne Poulenc Rorer Sa filed Critical Rh Ne Poulenc Rorer Sa
Publication of NO983472D0 publication Critical patent/NO983472D0/no
Publication of NO983472L publication Critical patent/NO983472L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Nye «axoider med den genere.le forme, (.), der Z betyr et hydrogenatom eller en res, med den generelle forme (I. der R, be,y en bloylres, som eventuelt er substituert med R,0-C0-, der R2 betyr a.koyl, a.kenyl, alkyny., cyk.oalkoy, cykloa, enyl, b.ykloa, oy eventuelt substituert fenyl. R3 betyr alkoyl, alkenyl, alkynyl, cykloalkoyl, fenyl. nafty. eller en aromat.sk heterocyke R4 betyr hydrok elter en rest alkoksy, aikenyloksy, alkynyloksy, alkoksyacety, eller alkoy.oksykarbonyloksy, e,,er cykloalkoylo sy e er cykloa, eny, eller arylkarbonyloksy eller hcteroeyklylkarbonyloksy, og Rs betyr alkoksy som eventuelt er substituert med cykloalkoyloksy eller eyklo- alkenyloksy. Forbindelsenes fremstilling beskrives. Videre beskrives farmasøytiske preparater inneholdende forbindelsene. Forbindelsene med forme. (I) der Z, betyr en res, med den generelle formel (II) oppviser interessante antUumorale og an,,.eukem,ske egenskaper.
NO983472A 1996-03-06 1998-07-28 Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene NO983472L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602804A FR2745814B1 (fr) 1996-03-06 1996-03-06 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/000386 WO1997032869A1 (fr) 1996-03-06 1997-03-05 Taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO983472D0 NO983472D0 (no) 1998-07-28
NO983472L true NO983472L (no) 1998-07-28

Family

ID=9489910

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983472A NO983472L (no) 1996-03-06 1998-07-28 Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene

Country Status (34)

Country Link
US (1) US6160135A (no)
EP (1) EP0885208B1 (no)
JP (1) JP2000506158A (no)
KR (1) KR19990087398A (no)
CN (1) CN1210525A (no)
AP (1) AP1023A (no)
AT (1) ATE204266T1 (no)
AU (1) AU715228B2 (no)
BG (1) BG63693B1 (no)
BR (1) BR9707887A (no)
CA (1) CA2248195A1 (no)
CZ (1) CZ283498A3 (no)
DE (1) DE69706146T2 (no)
DK (1) DK0885208T3 (no)
EA (1) EA001516B1 (no)
EE (1) EE03611B1 (no)
ES (1) ES2161446T3 (no)
FR (1) FR2745814B1 (no)
GE (1) GEP20012517B (no)
GR (1) GR3036410T3 (no)
HU (1) HUP9902425A3 (no)
IL (1) IL125998A (no)
IS (1) IS4809A (no)
NO (1) NO983472L (no)
NZ (1) NZ331040A (no)
OA (1) OA10855A (no)
PL (1) PL328691A1 (no)
PT (1) PT885208E (no)
SK (1) SK121598A3 (no)
TR (1) TR199801732T2 (no)
TW (1) TW474928B (no)
WO (1) WO1997032869A1 (no)
YU (1) YU38398A (no)
ZA (1) ZA971746B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
WO1999032473A1 (fr) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Derives de taxane
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
US6660866B2 (en) 2000-02-02 2003-12-09 Psu Research Foundation, Inc. C10 carbonate substituted taxanes
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
EP1737444A4 (en) 2004-03-05 2008-05-21 Univ Florida State Res Found C7-LACTYLOXA-SUBSTITUTED TAXANE
WO2009023967A1 (en) * 2007-08-22 2009-02-26 6570763 Canada Inc. Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
MX336339B (es) 2009-10-29 2016-01-14 Aventis Pharma Sa Nuevo uso antitumoral de cabazitaxel.
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
EP0555485A4 (en) * 1991-07-17 1993-11-03 Nippon Steel Corporation Antitumor compound nsc-lsc1 and production thereof
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
WO1994021250A1 (en) * 1993-03-22 1994-09-29 Florida State University Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
SK281526B6 (sk) * 1994-07-26 2001-04-09 Indena S. P. A. Semisyntetický taxán, spôsob jeho prípravy a medziprodukt, semisyntetický sekotaxán, spôsob jeho prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
US6201140B1 (en) * 1994-07-28 2001-03-13 Bristol-Myers Squibb Company 7-0-ethers of taxane derivatives

Also Published As

Publication number Publication date
EE03611B1 (et) 2002-02-15
CZ283498A3 (cs) 1999-01-13
EE9800264A (et) 1999-02-15
CA2248195A1 (fr) 1997-09-12
KR19990087398A (ko) 1999-12-27
HUP9902425A2 (hu) 2001-04-28
PL328691A1 (en) 1999-02-15
HUP9902425A3 (en) 2001-08-28
IL125998A (en) 2002-02-10
NO983472D0 (no) 1998-07-28
CN1210525A (zh) 1999-03-10
BG63693B1 (bg) 2002-09-30
US6160135A (en) 2000-12-12
DE69706146T2 (de) 2002-05-02
IL125998A0 (en) 1999-04-11
TW474928B (en) 2002-02-01
OA10855A (fr) 2003-02-05
FR2745814B1 (fr) 1998-04-03
JP2000506158A (ja) 2000-05-23
SK121598A3 (en) 1999-01-11
IS4809A (is) 1998-07-24
ZA971746B (en) 1997-09-16
PT885208E (pt) 2001-11-30
EA199800795A1 (ru) 1999-02-25
ES2161446T3 (es) 2001-12-01
TR199801732T2 (xx) 1998-12-21
GR3036410T3 (en) 2001-11-30
GEP20012517B (en) 2001-08-27
NZ331040A (en) 2000-02-28
BR9707887A (pt) 1999-09-21
FR2745814A1 (fr) 1997-09-12
AU2030297A (en) 1997-09-22
ATE204266T1 (de) 2001-09-15
AP1023A (en) 2001-11-16
AU715228B2 (en) 2000-01-20
EA001516B1 (ru) 2001-04-23
BG102753A (en) 1999-09-30
YU38398A (sh) 1999-07-28
DK0885208T3 (da) 2001-10-15
EP0885208A1 (fr) 1998-12-23
EP0885208B1 (fr) 2001-08-16
AP9801335A0 (en) 1998-09-30
WO1997032869A1 (fr) 1997-09-12
DE69706146D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
NO983472L (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
PL344012A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
NO20024176D0 (no) Farmasöytiske praparater inneholdende 3-amino- azetidinderivater, de nye derivater og deres fremstilling
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
RO82508B (ro) PROCEDEU PENTRU PREPARAREA UNOR DERIVATI DE 3-(1-PIPERIDINILACHIL)-4H-PIRIDO-(1,2-a)- PIRIMIDIN-4-ONA
DK0519327T3 (da) N-Acyl-S-(2-hydroxyalkyl) -cysteiner, deres fremstilling samt deres anvendelse som mellemprodukter til fremstilling af synt
ES483311A1 (es) Un procedimiento para preparar derivados de prolina
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
NO20040881L (no) Orale antidiabetes midler.
NO944930L (no) Hemming av dysfunksjonell uterin blödning
ATE297903T1 (de) Substituierte phenyluracile
ZA982137B (en) Cycloalkylalkanecarboxamides and their preparation and use.
MY147948A (en) 4- imidazolin-2-one compounds
DK0736012T3 (da) Anellerede dihydropyridiner og deres anvendelse til fremstilling af farmaceutiske præparater
HUP0104620A2 (hu) 2-Fenil-pirán-4-on-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO20023251D0 (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
YU72095A (sh) Nove herbicidne kompozicije
SE8303913L (sv) Heterocykliska foreningar
NO944577L (no) Hemming av effekten av amyloidogene proteiner
DK0420224T3 (da) Anthihepatopatisk middel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application